Jinyu Bio-technology Co., Ltd. (SHA:600201)
China · Delayed Price · Currency is CNY 12.64
+0.92 (7.85%)
Jul 31, 2026, 3:00 PM CST
Jinyu Bio-technology Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,391 | 1,396 | 1,255 | 1,598 | 1,529 | 1,776 |
Revenue Growth | 10.50% | 11.23% | -21.45% | 4.55% | -13.94% | 12.29% |
Gross Profit Gross Profit Growth | 724.94 | 731.35 | 658.29 | 930.13 | 831.37 | 1,088 |
Operating Income Operating Income Growth | -1.8 | 3.72 | 37.19 | 248.7 | 252.01 | 394.19 |
Net Income Net Income Growth | 104.27 | 100.11 | 108.99 | 283.63 | 210.66 | 382.29 |
Earnings Per Share EPS Growth | 0.09 | 0.09 | 0.10 | 0.26 | 0.19 | 0.34 |
EPS Growth | 27.27% | -10.00% | -61.54% | 36.84% | -44.12% | -5.56% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Other income Other income Growth | 48.6 |
Biopharmaceutical Biopharmaceutical Growth | 1,294 |
Total Total Growth | 1,343 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,320 | 1,385 | 1,176 | 1,749 | 1,452 | 1,518 |
Total Debt Total Debt Growth | 1.2 | 1.58 | 17.74 | 4.27 | 10.85 | 0.78 |
Net Cash (Debt) Net Cash Growth | 1,319 | 1,383 | 1,159 | 1,745 | 1,442 | 1,517 |
Net Cash Growth | 28.10% | 19.41% | -33.61% | 21.07% | -4.99% | -29.61% |
Net Cash Per Share Net Cash Per Share Growth | 1.17 | 1.24 | 1.06 | 1.60 | 1.30 | 1.35 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 301.31 | 316.12 | 289.55 | 414.83 | 344.65 | 533.08 |
Capital Expenditures CapEx Growth | -145.88 | -121.43 | -89.67 | -273.17 | -190.11 | -372.68 |
Free Cash Flow Free Cash Flow Growth | 155.42 | 194.69 | 199.89 | 141.67 | 154.54 | 160.4 |
Free Cash Flow Growth | -23.30% | -2.60% | 41.09% | -8.33% | -3.65% | -65.97% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 52.11% | 52.37% | 52.43% | 58.20% | 54.38% | 61.22% |
Operating Margin | -0.13% | 0.27% | 2.96% | 15.56% | 16.49% | 22.19% |
Pretax Margin | 7.57% | 7.49% | 9.95% | 19.76% | 16.07% | 23.27% |
Profit Margin | 7.50% | 7.17% | 8.68% | 17.75% | 13.78% | 21.52% |
FCF Margin | 11.17% | 13.94% | 15.92% | 8.86% | 10.11% | 9.03% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.037 | 0.037 | 0.030 | 0.080 | 0.060 | 0.110 |
Dividend Per Share Growth | 23.33% | 23.33% | -62.50% | 33.33% | -45.45% | -8.33% |
Dividend Yield | 0.29% | 0.25% | 0.44% | 0.76% | 0.68% | 0.70% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 136.64 | 164.49 | 70.31 | 41.29 | 46.74 | 47.84 |
Forward PE | 53.47 | 82.58 | 21.05 | 31.48 | 23.75 | 22.33 |
P/FCF Ratio | 88.87 | 84.58 | 38.34 | 82.67 | 63.71 | 114.01 |
PS Ratio | 9.93 | 11.79 | 6.10 | 7.33 | 6.44 | 10.30 |